A Phase 4 Study of Efficacy and Safety of Dulaglutide When Added to Insulin Treatment With or Without Oral Antidiabetic Medication in Patients With Type 2 Diabetes
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 07 Jun 2017 Biomarkers information updated
- 25 May 2017 Planned End Date changed from 1 Jul 2018 to 1 Jun 2018.
- 25 May 2017 Status changed from recruiting to active, no longer recruiting.